CancerNetwork Members: Login | Register
 
CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
PATIENTS
NURSES
JOBS
CONFERENCES
CME
SUPPLEMENTS
 
Home » Lung Cancer

ONCOLOGY Nurse Edition. Vol. 24 No. 4
Pages: 1  2  3  4  
Next
 

Screening for Emotional Distress in Older Patients With Lung Cancer

By Terry Badger, PhD,
PMHCNS-BC, FAAN

Virginia T. LeBaron, MS,
ACNP-BC, AOCN, ACHPN

Ruth McCorkle, PhD,
RN, FAAN | April 9, 2010
Terry Badger is Professor and Director, Division of Nursing Systems, at The University of Arizona College of Nursing, Tucson; Virginia T. LeBaron is Clinical Associate Professor and Acute Care Nurse Practitioner at The University of Arizona College of Nursing; and Ruth McCorkle is Florence S. Wald Professor and Director, Center for Excellence in Chronic Illness, Yale University School of Nursing, New Haven, Connecticut. Financial Disclosure: The authors have no significant financial interest or other relationship with the manufacturers of any products or providers of any service mentioned in this article.

An estimated 219,440 new cases of lung cancer were expected in 2009, accounting for about 15% of cancer diagnoses.[1] Most cancer-related deaths in both men and women are attributable to lung cancer, which represents about 28% of all cancer deaths. Lung cancer patients are often older, with approximately 60% of cancer diagnoses and 70% of cancer mortality occurring in those over the age of 65 years.[2]

The two major types of lung cancer are non–small-cell lung cancer (NSCLC), representing 80% to 85% of all lung cancers, and small-cell lung cancer (SCLC), which represents 15% to 20%. Surgery is the primary treatment modality for early stage I and II NSCLC. If NSCLC is diagnosed at a later stage, radiation is used for control and chemotherapy is used for advanced and metastatic disease. Limited SCLC disease is treated with chemotherapy and radiation, whereas more extensive disease is treated with chemotherapy alone.[3]

Older adults are more likely to have concurrent diseases (eg, diabetes, chronic obstructive pulmonary disease, heart disease, arthritis, hypertension) which can exacerbate complications from cancer[4] and reduce treatment tolerance and life expectancy.[5] Although the relative survival rate for older lung cancer survivors is increasing, largely as a result of improvements in surgical treatments and combined therapies (eg, surgery, radiation, chemotherapy, and targeted biological therapies), older lung cancer patients may suffer from severe psychological distress.

Psychological distress, particularly depression and anxiety, has been well documented in adults diagnosed with cancer[6] but prevalence rates for distress vary by type of cancer. Prevalence rates of up to 43.5% for lung cancer patients have been reported,[7] and rates of 41% have been found for older adults.[8] It is clear that older lung cancer patients are at risk for developing severe psychological distress—distress that is often unrecognized or untreated.

Psychological distress is an important problem in cancer survivorship because it significantly influences cancer recovery and quality of life (QOL).[9] Symptoms of depression, for example, are associated with decreased compliance with adjuvant therapy and a variety of cognitive and functional impairments.[6] Psychological distress has been linked to decreased immune function,[10] response to chemotherapy observed by tumor size,[10] and when severe and persistent, to long-term survival.[11] Psychological distress in older cancer survivors can increase treatment-related side effects and decrease abilities to manage their symptoms, adding to the burden of the illness.[12] Untreated psychological distress has been linked to suicide in older adults, with the rates of suicide in cancer patients twice that of the general population.[13]

People with lung cancer are acknowledged to have more unmet needs and greater distress than people with other cancers. In part, this is because there is no effective method for early detection and the majority of people with lung cancer are diagnosed with advanced disease. Patients report both physical and psychological symptoms across the disease course.

Pages: 1  2  3  4  
Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
RELATED CONTENT

New Testing for Lung Cancer Screening
ONCOLOGY,  February 9, 2012
Immunomodulation May Be New Useful Approach to Treat Lung Cancer
January 5, 2012
New Mutation May Act as Driver in Subset of Lung Cancer Patients
January 4, 2012
Lung Cancer Deaths Not Reduced by Chest X-Ray Screening
October 26, 2011
Erlotinib as Maintenance Therapy Shows PFS Benefit for Lung Cancer Patients with EGFR-Mutated Tumors
ONCOLOGY,  October 5, 2011
 
CANCER MANAGEMENT

Non–small-cell lung cancer
     Screening and Prevention
     Signs and Symptoms
     Staging and Prognosis
     Treatment
Small-cell lung cancer
Mesothelioma
Thymoma
 
TOPIC INDEX

  • Bladder Cancer
  • Bone Metastases
  • Breast Cancer
  • CML
  • Colorectal Cancer
  • End-of-Life
  • GIST
  • Genetics Genomics
  • Gynecologic Cancers
  • Head & Neck Cancer
  • Integrative Oncology
  • Leukemia
  • Lung Cancer
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Nausea & Vomiting
  • Palliative Care
  • Pancreatic Cancer
  • Practice Management
  • Practice & Policy
  • Prostate Cancer
  • RCC
  • Skin Cancer
  • Triple-Negative Breast
  • Testicular Cancer


More Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
'What They Should Really Teach in Medical School'
Julie Schopps, MD , February 6, 2012
The North Carolina-based pediatrician weighs in on why she thinks the real learning doesn't take place until students are out of the classroom.
Improve EHR Systems by Rethinking Medical Billing
Daniel Essin, MA, MD, February 6, 2012
Separating billing-related data from other clinical documentation and transmitting it to a billing system is not difficult …no matter how the charting is done.
Keeping Your Medical Practice’s Accounts Receivable on Track
P.J. Cloud-Moulds, February 4, 2012
Here are the minimum reports you should be running to keep an eye on your practices A/R.
Healthcare Providers Play Crucial Role in Helping Victims of Abuse
Stephen Hanson, PA-C , February 3, 2012
I would urge each and every one of you to be familiar with the warning signs of abuse, and the resources available to you all as healthcare providers.
Protecting Your Medical Practice's Data
Marisa Torrieri, February 3, 2012
Here's the scoop on how to implement a good data-backup plan at your office.
 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Management of Brain Metastases: Neurosurgical Considerations
  • Optimizing Outcomes of Advanced Prostate Cancer: Drug Sequencing and Novel Therapeutic Approaches
  • Head and Neck Tumors
  • A 28-Year-Old Woman Presents With a Long-Standing History of Intermittently Painful “Bumps” on Both Her Shoulders and Upper Back
  • Controversies in Oncologist-Patient Communication: A Nuanced Approach to Autonomy, Culture, and Paternalism
  • Ending the Shortage of Generic Oncology Drugs
  • Processed and Red Meat Consumption Linked to Slight Increase in Risk of Pancreatic Cancer
  • Controversies in Oncologist-Patient Communication: A Nuanced Approach to Autonomy, Culture, and Paternalism
  • Younger Breast Cancer Patients Have More Adverse Quality of Life Issues
  • New Way to Predict Prostate Cancer Severity—Size of Prostate
  • AL Amyloidosis: Who, What, When, Why, and Where
  • The Maze of PARP Inhibitors in Ovarian Cancer
  • The Circuitous Path of PARP Inhibitor Development in Epithelial Ovarian Cancer
  • Podcast: Dr. David Ahlquist on Advances in Colorectal Cancer Screening
  • Lung Cancer Screening: A New Era
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • When to Treat Myelodysplastic Syndromes
  • ASCO 2011: A Paradigm Shift in the Treatment of Endometrial Cancer
  • PSA Screening for Prostate Cancer Put Into Question By the U.S. Preventive Services Task Force
  • PSA Screening for Prostate Cancer Put Into Question By the U.S. Preventive Services Task Force
  • When to Treat Myelodysplastic Syndromes
  • ASCO 2011: A Paradigm Shift in the Treatment of Endometrial Cancer
  • Are We Ready for Neoadjuvant Therapy in Potentially Resectable Pancreatic Cancer?
  • Evolving Therapeutic Paradigms for Advanced Prostate Cancer
Click here to subscribe to our newsletter
 
JOB LISTINGS

Post a job

Powered by SearchMedica Jobs


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Lung Cancer
Evidence on Lung Cancer
Guidelines on Lung Cancer
Patient Education on Lung Cancer
Clinical Trials on Lung Cancer
Practical Articles on Lung Cancer
Research and Reviews on Lung Cancer
All "Lung Cancer" results

CancerNetwork | CME LLC | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2012 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy